Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report 2025(Status and Outlook)

March 2025 | 234 pages | ID: G6BC9BDAB3C5EN
Bosson Research

Abstracts

Report Overview

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

This report provides a deep insight into the global Beta-Nicotinamide Mononucleotide (NMN) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Beta-Nicotinamide Mononucleotide (NMN) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Beta-Nicotinamide Mononucleotide (NMN) market in any manner.

Global Beta-Nicotinamide Mononucleotide (NMN) Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GeneHarbor

Herbalmax

Genex Formulas

Mirailab Bioscience

Maac10 Formulas

EffePharm

Bontac

CELFULL

Kingdomway

Market Segmentation (by Type)

Content ?98%

Content ?98%

Market Segmentation (by Application)

Health Care Products

Cosmetics

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Beta-Nicotinamide Mononucleotide (NMN) Market
• Overview of the regional outlook of the Beta-Nicotinamide Mononucleotide (NMN) Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Beta-Nicotinamide Mononucleotide (NMN) Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Beta-Nicotinamide Mononucleotide (NMN)
1.2 Key Market Segments
  1.2.1 Beta-Nicotinamide Mononucleotide (NMN) Segment by Type
  1.2.2 Beta-Nicotinamide Mononucleotide (NMN) Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Product Life Cycle
3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (2020-2025)
3.4 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers (2020-2025)
3.5 Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Sites, Area Served, Product Type
3.8 Beta-Nicotinamide Mononucleotide (NMN) Market Competitive Situation and Trends
  3.8.1 Beta-Nicotinamide Mononucleotide (NMN) Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Beta-Nicotinamide Mononucleotide (NMN) Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) INDUSTRY CHAIN ANALYSIS

4.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Beta-Nicotinamide Mononucleotide (NMN) Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Beta-Nicotinamide Mononucleotide (NMN) Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET BY REGION

6.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
  6.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
  6.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Market Share by Region
6.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Region
  6.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Region
  6.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type
7.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type
8.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type
9.3 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type
10.3 South America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type
11.3 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application

12 BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET PRODUCTION BY REGION

12.1 Global Production of Beta-Nicotinamide Mononucleotide (NMN) by Region(2020-2025)
12.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2020-2025)
12.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Beta-Nicotinamide Mononucleotide (NMN) Production
  12.4.1 North America Beta-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2020-2025)
  12.4.2 North America Beta-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Beta-Nicotinamide Mononucleotide (NMN) Production
  12.5.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2020-2025)
  12.5.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Beta-Nicotinamide Mononucleotide (NMN) Production (2020-2025)
  12.6.1 Japan Beta-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2020-2025)
  12.6.2 Japan Beta-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Beta-Nicotinamide Mononucleotide (NMN) Production (2020-2025)
  12.7.1 China Beta-Nicotinamide Mononucleotide (NMN) Production Growth Rate (2020-2025)
  12.7.2 China Beta-Nicotinamide Mononucleotide (NMN) Production, Revenue, Price and Gross Margin (2020-2025)

13 BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2020-2033)
13.3 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Market Share by Type (2020-2033)
13.4 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type (2020-2033)

14 BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Beta-Nicotinamide Mononucleotide (NMN) Market Sales by Application (2020-2033)
14.3 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application (2020-2033)
14.4 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 GeneHarbor
  15.1.1 GeneHarbor Basic Information
  15.1.2 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Overview
  15.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Market Performance
  15.1.4 GeneHarbor Business Overview
  15.1.5 GeneHarbor SWOT Analysis
  15.1.6 GeneHarbor Recent Developments
15.2 Herbalmax
  15.2.1 Herbalmax Basic Information
  15.2.2 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Overview
  15.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Market Performance
  15.2.4 Herbalmax Business Overview
  15.2.5 Herbalmax SWOT Analysis
  15.2.6 Herbalmax Recent Developments
15.3 Genex Formulas
  15.3.1 Genex Formulas Basic Information
  15.3.2 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Overview
  15.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Market Performance
  15.3.4 Genex Formulas Business Overview
  15.3.5 Genex Formulas SWOT Analysis
  15.3.6 Genex Formulas Recent Developments
15.4 Mirailab Bioscience
  15.4.1 Mirailab Bioscience Basic Information
  15.4.2 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Product Overview
  15.4.3 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Product Market Performance
  15.4.4 Mirailab Bioscience Business Overview
  15.4.5 Mirailab Bioscience Recent Developments
15.5 Maac10 Formulas
  15.5.1 Maac10 Formulas Basic Information
  15.5.2 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Overview
  15.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Market Performance
  15.5.4 Maac10 Formulas Business Overview
  15.5.5 Maac10 Formulas Recent Developments
15.6 EffePharm
  15.6.1 EffePharm Basic Information
  15.6.2 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Overview
  15.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Market Performance
  15.6.4 EffePharm Business Overview
  15.6.5 EffePharm Recent Developments
15.7 Bontac
  15.7.1 Bontac Basic Information
  15.7.2 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Overview
  15.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Market Performance
  15.7.4 Bontac Business Overview
  15.7.5 Bontac Recent Developments
15.8 CELFULL
  15.8.1 CELFULL Basic Information
  15.8.2 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Overview
  15.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Market Performance
  15.8.4 CELFULL Business Overview
  15.8.5 CELFULL Recent Developments
15.9 Kingdomway
  15.9.1 Kingdomway Basic Information
  15.9.2 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Overview
  15.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Market Performance
  15.9.4 Kingdomway Business Overview
  15.9.5 Kingdomway Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type (M USD)
Table 4. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application (M USD)
Table 5. Beta-Nicotinamide Mononucleotide (NMN) Market Size Comparison by Region (M USD)
Table 6. Global Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Beta-Nicotinamide Mononucleotide (NMN) as of 2024)
Table 11. Global Market Beta-Nicotinamide Mononucleotide (NMN) Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Sites and Area Served
Table 13. Manufacturers Beta-Nicotinamide Mononucleotide (NMN) Product Type
Table 14. Global Beta-Nicotinamide Mononucleotide (NMN) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Beta-Nicotinamide Mononucleotide (NMN) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Beta-Nicotinamide Mononucleotide (NMN) Market Size Comparison by Region (M USD)
Table 26. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region (2020-2033) & (M USD)
Table 27. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Market Share by Region (2020-2033)
Table 28. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2020-2033) & (K MT)
Table 29. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2020-2033)
Table 30. North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country (2020-2033) & (M USD)
Table 31. North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2020-2033) & (K MT)
Table 32. North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (K MT)
Table 33. North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type (M USD)
Table 34. North America Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Type (2020-2033)
Table 35. North America Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Type (2020-2033)
Table 36. North America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (K MT)
Table 37. North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application (M USD)
Table 38. North America Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Application (2020-2033)
Table 39. North America Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application (2020-2033)
Table 40. Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2020-2033) & (K MT)
Table 42. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (K MT)
Table 43. Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type (M USD)
Table 44. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Type (2020-2033)
Table 45. Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Type (2020-2033)
Table 46. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (K MT)
Table 47. Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application (M USD)
Table 48. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Application (2020-2033)
Table 49. Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (K MT)
Table 53. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type (M USD)
Table 54. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (K MT)
Table 57. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application (M USD)
Table 58. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application (2020-2025)
Table 60. South America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country (2020-2033) & (M USD)
Table 61. South America Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2020-2033) & (K MT)
Table 62. South America Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (K MT)
Table 63. South America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type (M USD)
Table 64. South America Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Type (2020-2033)
Table 65. South America Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Type (2020-2033)
Table 66. South America Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (K MT)
Table 67. South America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application (M USD)
Table 68. South America Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Application (2020-2033)
Table 69. South America Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (K MT)
Table 73. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type (M USD)
Table 74. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (K MT)
Table 77. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application (M USD)
Table 78. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application (2020-2033)
Table 80. Global Beta-Nicotinamide Mononucleotide (NMN) Production (K MT) by Region(2020-2025)
Table 81. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2020-2025)
Table 83. Global Beta-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Beta-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Beta-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Beta-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Beta-Nicotinamide Mononucleotide (NMN) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (K MT)
Table 89. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type (M USD)
Table 90. Global Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Type (2020-2033)
Table 91. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2020-2033)
Table 92. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Type (2020-2033)
Table 93. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Share by Type (2020-2033)
Table 94. Global Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) by Application
Table 95. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application(M USD)
Table 96. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2020-2033) & (K MT)
Table 97. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2020-2033)
Table 98. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application (2020-2033) & (M USD)
Table 99. Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Application (2020-2033)
Table 100. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Growth Rate by Application (2020-2033)
Table 101. GeneHarbor Basic Information
Table 102. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Overview
Table 103. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. GeneHarbor Business Overview
Table 105. GeneHarbor SWOT Analysis
Table 106. GeneHarbor Recent Developments
Table 107. Herbalmax Basic Information
Table 108. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Overview
Table 109. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Herbalmax Business Overview
Table 111. Herbalmax SWOT Analysis
Table 112. Herbalmax Recent Developments
Table 113. Genex Formulas Basic Information
Table 114. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Overview
Table 115. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Genex Formulas Business Overview
Table 117. Genex Formulas SWOT Analysis
Table 118. Genex Formulas Recent Developments
Table 119. Mirailab Bioscience Basic Information
Table 120. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Product Overview
Table 121. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Mirailab Bioscience Business Overview
Table 123. Mirailab Bioscience Recent Developments
Table 124. Maac10 Formulas Basic Information
Table 125. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Overview
Table 126. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Maac10 Formulas Business Overview
Table 128. Maac10 Formulas Recent Developments
Table 129. EffePharm Basic Information
Table 130. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Overview
Table 131. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. EffePharm Business Overview
Table 133. EffePharm Recent Developments
Table 134. Bontac Basic Information
Table 135. Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Overview
Table 136. Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Bontac Business Overview
Table 138. Bontac Recent Developments
Table 139. CELFULL Basic Information
Table 140. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Overview
Table 141. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. CELFULL Business Overview
Table 143. CELFULL Recent Developments
Table 144. Kingdomway Basic Information
Table 145. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Overview
Table 146. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Kingdomway Business Overview
Table 148. Kingdomway Recent Developments
List of Figures
Figure 1. Product Picture of Beta-Nicotinamide Mononucleotide (NMN)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD), 2024-2033
Figure 5. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) (2020-2033)
Figure 6. Global Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Beta-Nicotinamide Mononucleotide (NMN) Product Life Cycle
Figure 13. Beta-Nicotinamide Mononucleotide (NMN) Sales Share by Manufacturers in 2024
Figure 14. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Share by Manufacturers in 2024
Figure 15. Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Beta-Nicotinamide Mononucleotide (NMN) Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Beta-Nicotinamide Mononucleotide (NMN) Revenue in 2024
Figure 18. Industry Chain Map of Beta-Nicotinamide Mononucleotide (NMN)
Figure 19. Global Beta-Nicotinamide Mononucleotide (NMN) Market PEST Analysis
Figure 20. Global Beta-Nicotinamide Mononucleotide (NMN) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
Figure 27. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Market Share by Region (2020-2033)
Figure 28. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Country
Figure 33. USA Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Beta-Nicotinamide Mononucleotide (NMN) Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Beta-Nicotinamide Mononucleotide (NMN) Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD)by Type
Figure 40. North America Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Country
Figure 45. Germany Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Type
Figure 56. Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Country
Figure 61. China Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Type
Figure 72. Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Country
Figure 77. Brazil Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Type
Figure 84. South America Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Country
Figure 89. Saudi Arabia Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Beta-Nicotinamide Mononucleotide (NMN) Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Type
Figure 100. Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size (M USD) by Application
Figure 101. Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2020-2025)
Figure 102. North America Beta-Nicotinamide Mononucleotide (NMN) Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Beta-Nicotinamide Mononucleotide (NMN) Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Beta-Nicotinamide Mononucleotide (NMN) Production (K MT) Growth Rate (2020-2025)
Figure 105. China Beta-Nicotinamide Mononucleotide (NMN) Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Type (M USD)
Figure 108. Sales Market Share of Beta-Nicotinamide Mononucleotide (NMN) by Type (2020-2033)
Figure 109. Sales Market Share of Beta-Nicotinamide Mononucleotide (NMN) by Type in 2024
Figure 110. Market Size Share of Beta-Nicotinamide Mononucleotide (NMN) by Type (2020-2033)
Figure 111. Market Size Share of Beta-Nicotinamide Mononucleotide (NMN) by Type in 2024
Figure 112. Global Beta-Nicotinamide Mononucleotide (NMN) Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Application(M USD)
Figure 115. Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Application
Figure 116. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2020-2033)
Figure 117. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application in 2024
Figure 118. Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Application (2020-2033)
Figure 119. Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Application in 2024
Figure 120. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Growth Rate by Application (2020-2033)